Skip to content

Prospective capillaroscopic observation of angiogenesis and new induction vessels by warming in systemic sclerosis

Prospective capillaroscopic observation of angiogenesis and new induction vessels by warming in systemic sclerosis - AGNI study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000041821
Enrollment
20
Registered
2020-09-26
Start date
2020-10-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Systemic sclerosis

Interventions

Warming the upper lateral surface areas of both elbow joints using disposable warmer pads.

Sponsors

Osaka University Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients over 20 years old and under 90 years old. 2. Patients who have Raynaud's phenomenon(RP) and meet the 2013 Classification Criteria for Systemic Sclerosis (ACR/EAULAR). 3. Patients visiting the outpatient of Osaka University Hospital. 4. Patients who give written informed consent.

Exclusion criteria

Exclusion criteria: 1. Another skin disease except systemic sclerosis at the site of wearing 2. Chronic febrile disease including infectious disease 3. Diabetes mellitus 4. Incapable of taking off the warmer by themselves 5. Peripheral neuropathy of upper extremities or past medical history of that 6. Vascular shunt on the arm for hemodialysis 7. Others (judged as ineligible by the responsible researcher)

Design outcomes

Primary

MeasureTime frame
Capillary density of the nail fold observed by capillaroscopy

Secondary

MeasureTime frame
Morphological modification of the nail fold capillary observed by capillaroscopy, The concentrations of angiogenesis related factors in fingertip blood (angiopoietin-1, angiopoietin-2, endostatin, VEGF)

Countries

Japan

Contacts

Public ContactYoshihito Shima

Osaka University Graduate School of Medicine Laboratory of Thermo-therapeutics for vascular dysfunction

ryanjin@imed3.med.osaka-u.ac.jp06-6105-5710

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026